Treatment is a combination of antibiotics and acid-reducing medication, and it is highly effective
By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer packaged goods (CPG) market researcher projected
There are no licensed retatrutide products on sale anywhere in the world as of May 2026
Copper is only required in trace amounts by the body, and too much copper buildup could theoretically cause nausea, abdominal pain, tiredness, liver damage, and neurological effects
25% of all discontinuations happen this week
What storage conditions are required for GLP-1 peptides